• Ann Clements, Sucheta Jindal, Chris Morris, Garima Srivastava, Amaju Ikomi, and John Mulholland.
• Department of Clinical Perfusion Science, Essex Cardiothoracic Centre, Basildon & Thurrock University Hospital, Nethermayne, Essex, UK. ann.clements@btuh.nhs.uk
• Perfusion. 2011 May 1; 26 (3): 181-4.

AbstractIt is important that our speciality continues to push its boundaries. Our perfusion team has invested time lecturing to non-cardiac specialties about perfusion-led technology. This resulted in working closely with the obstetrics team to treat a pregnant patient with the bleeding disorder Gray Platelet Syndrome. In the first instance, we used our Thromboelastograph (TEG) platelet mapping programme to assess the patient. These results agreed with the platelet aggregation tests, showing a degree of platelet inhibition, but it was the overall clotting profile (basic thrombelastograph), showing a borderline hyper-coagulable state, that was of most interest and commonly seen in pregnancy. We believe a TEG result within acceptable limits could help re-adjust the risk of spinal haematomas following regional anaesthesia, thereby, reducing the risks of difficult intubation and general anaesthetic exposure to the baby. The case study describes both basic and platelet mapping thrombelastographs and their potential role in not only this patient with Gray Platelet Syndrome, but any obstetric patient where there are bleeding concerns.

15 keywords...

hide…